## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-22T11:05:40.358Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "ASRA Coags" developer_entity: "American Society of Regional Anesthesia and Pain Medicine" bundle_id: "com.ASRA.ASRACoags" app_store_id: "858796572" google_play_id: "com.asra.asracoags" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2025-12-03" report_date: "2026-05-22" last_verified: "2026-05-22" report_version: "6.1" total_reviews: 578 overall_rating: 1.23 sentiment: "Upset" sentiment_score: 15 confidence: "high" confidence_score: 0.7 top_praise_theme: "Clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals" top_complaint_theme: "Forced subscription model revokes lifetime access previously purchased by long-term medical professional users" top_request_theme: "Restoration of access for users who previously paid for lifetime ownership of the application" review_sample_size: 49 total_review_count: 49 analyzed_review_count: 49 data_age_days: 0 momentum_velocity: "steady" intelligence_version: 3 nemesis: "Vargo Anesthesia Mega App" competitor_count: 7 tags: ["medical", "subscription", "upset sentiment", "mobile app", "app review", "app analysis", "anesthesiologists,", "medicine", "specialists,"] canonical_url: "https://marlvel.ai/intel-report/medical/asra-coags" license: "CC-BY-NC 4.0" content_version: "v2" --- # ASRA Coags App Audit ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 1.23 · Sentiment Upset - **Recent focus**: Forced subscription model revokes lifetime access previously purchased by long-term medical professional users (top complaint) · Clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals (top praise) · Restoration of access for users who previously paid for lifetime ownership of the application (top request) > **TL;DR:** ASRA Coags is a medical app by American Society of Regional Anesthesia and Pain Medicine, rated 1.23/5 by 578 users, with Upset user sentiment (15/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** ASRA Coags faces Upset user sentiment (1.23/5 from 578 reviews), with forced subscription model revokes lifetime access previously purchased by long-term medical professional users as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 1.23/5 (578 reviews) | | **User Mood** | Upset | | **Category** | Medical | | **Developer** | American Society of Regional Anesthesia and Pain Medicine | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | High (0.7/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** American Society of Regional Anesthesia and Pain Medicine - **Category:** Medical - **Target Audience:** Anesthesiologists, pain medicine specialists, and healthcare providers performing regional anesthesia or interventional pain procedures. - **Platforms:** iOS & Android - **Version Audited:** 6.1 - **Audit Date:** 2026-05-22 - **Signal Count:** 49 reviews analyzed - **Confidence:** High (0.7/1.0) - **App Store ID (iOS):** 858796572 - **Bundle ID:** com.ASRA.ASRACoags - **Google Play ID:** com.asra.asracoags - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-22 ## Executive Snapshot **What it is:** ASRA Coags is a medical reference app for anesthesiologists and pain specialists, providing searchable anticoagulation guidelines and procedure-based drug recommendations on iOS and Android. **Why users hire it:** Medical professionals hire this app to reduce clinical decision-making time during high-pressure procedures, using society-sanctioned data to ensure patient safety. ## App DNA (Features & Intent) - **[Differentiator] Anticoagulation Guideline Reference:** Searchable database of drug-specific recommendations for regional anesthesia and interventional pain procedures * *User Intent:* Users need clear guidance to understand and adopt the product quickly. - **[Standard] Procedure-Based Search:** Drug recommendations filtered by block type or procedure risk level * *User Intent:* Users want to quickly find relevant content or features. - **[Differentiator] Full Guideline Access:** In-app access to the full 2025 regional and 2018 interventional pain guideline documents * *User Intent:* Users need clear guidance to understand and adopt the product quickly. ## Market Position {#market-position} ASRA Coags holds a niche position in the medical category, but its 1.27-star rating across 578 total ratings indicates severe user dissatisfaction following the recent subscription transition. The lack of competitive feature parity with mega-apps like Vargo Anesthesia leaves the app vulnerable to churn. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free for ASRA Pain Medicine members, $6.99/annually for non-members - **Analysis:** Subscription model anchored at $6.99/year, utilizing the app as a membership retention tool for the professional society. ## 🔴 User Sentiment (High Confidence: 49 of 49 reviews analyzed) {#user-sentiment} - **Overall Rating:** 1.23/5 - **Platform Split:** iOS 1.3/5 (362 ratings) | Android 1.2/5 (216 ratings) - **Overall Sentiment:** Upset ### Top Praises - **Clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals** ### Top Complaints (Impact Areas) - **Forced subscription model revokes lifetime access previously purchased by long-term medical professional users** - **Lack of grandfathering for legacy users creates significant friction and loss of trust in the brand** ### Top Requests (What Users Want) - **Restoration of access for users who previously paid for lifetime ownership of the application** ## SWOT Analysis {#swot} **Core Strengths:** - Society-sanctioned clinical standards function as a primary distribution moat for professional practitioners. - Procedure-based search reduces clinical decision-making time, driving daily utility. **Critical Frictions:** - Subscription transition revoked lifetime access for legacy users, triggering a 1.27-star rating floor. - Technical instability and crashes reported following the latest update. **Growth Levers:** - Integration of wearable-based clinical alerts could provide a high-utility differentiator. - B2B partnerships with hospital systems could bypass individual subscription friction. **Market Threats:** - Vargo Anesthesia's nine-update-per-six-month cadence leaves ASRA Coags vulnerable to feature obsolescence. - Consolidated medical reference apps are siphoning screen time from single-purpose tools. ## Recent Changes (v2 → v3) {#recent-changes} The app's transition to a mandatory subscription model without legacy support has caused a severe decline in user sentiment and brand trust. **Overall trend**: Declining **Compared at**: 2026-05-22 ### High-impact changes - **[Shifted] Subscription Model Implementation** (pricing) — Transitioned from one-time purchase to $6.99/annually subscription with no grandfathering for legacy users. - **[Declined] Rating and Sentiment Collapse** (sentiment) — User rating dropped to 1.27 stars, with primary complaints focused on the revocation of lifetime access. ### Medium-impact changes - **[Improved] Feature Repositioning** (features) — Anticoagulation Guideline Reference and Full Guideline Access upgraded from standard to differentiator status. - **[Added] New Weaknesses and Threats** (swot) — Added technical instability and competitor update cadence (Vargo Anesthesia) as material risks to the app's market position. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### ASRA Coags vs Vargo Anesthesia Mega App — Head to Head - **[Vargo Anesthesia Mega App](https://marlvel.ai/intel-report/medical/com-insertnamehere-vargomasterapp)** by Vargo Anesthesia Inc: Dominates the anesthesia niche with a comprehensive, high-frequency update cycle that dwarfs specialized tools. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Aggressive release cadence of nine updates in six months ensures constant feature evolution and stability. - Consolidates multiple anesthesia tools into one mega-app, creating a high barrier to entry for single-purpose apps. ### Contenders (Strong Challengers) - **[Anesthesia Central](https://marlvel.ai/intel-report/medical/anesthesia-central-1)** by Unbound Medicine, Inc. [Moat: Medium]: Directly targets the same clinical audience with specialized anesthesia-focused reference content and decision support. - Integrates comprehensive drug databases and clinical calculators directly into the anesthesia reference workflow. - Leverages a professional-grade content platform that provides deeper clinical evidence than simple guideline-based apps. ### Peers (What They Do Better) - **[MDCalc Medical Calculator](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator)** by MD Aware, LLC: Provides essential clinical decision support tools that overlap with the procedural requirements of ASRA Coags users. - Offers a massive library of peer-reviewed calculators that serve as a daily utility for all medical specialties. - Utilizes a highly optimized, fast-loading interface that prioritizes quick clinical calculations over long-form guideline reading. - **[Calculate by QxMD](https://marlvel.ai/intel-report/medical/calculate-by-qxmd)** by WebMD: A broad-spectrum clinical tool that competes for the same limited screen time during high-pressure clinical procedures. - Provides seamless integration with institutional electronic health records to streamline clinical documentation workflows. - Maintains a vast, cross-specialty library that captures users who prefer one-stop-shop medical utility apps. - **[UpToDate](https://marlvel.ai/intel-report/medical/uptodate)** by UpToDate, Inc.: The industry standard for clinical evidence, often serving as the primary source of truth for the guidelines ASRA Coags references. - Provides exhaustive, evidence-based clinical summaries that act as the definitive source for complex medical decision-making. - Maintains a massive institutional subscription base that effectively locks out smaller, niche-specific reference applications. - **[Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10)** by Doximity: Captures the professional networking and clinical communication space, creating a high-frequency habit loop for physicians. - Combines professional networking, secure clinical communication, and medical news into a single, high-retention ecosystem. - Leverages a massive verified physician user base to drive engagement through professional utility rather than just reference. ### New Kids on the Block (What's Innovative) - **[Pedi STAT](https://marlvel.ai/intel-report/medical/com-qxmd-pedsguide)** by James M Kempema MD PA: Represents a specialized, high-utility niche tool that demonstrates how focused procedural apps can gain traction. ## App Momentum (Steady) {#momentum} - Implemented universal code base. - Integrated 2025 regional anesthesia guidelines. - Updated UI design. > **Cadence:** 5 total versions · 0 majors in last 6 months · 137 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} ASRA Coags is a challenged medical app that is available. With a 1.23/5 rating from 578 reviews, it faces significant user friction. > **Bottom Line:** ASRA Coags retains high clinical value, but the aggressive subscription pivot has alienated its core professional base, so the PM must prioritize grandfathering legacy users to halt the rating collapse. **Best for:** Anesthesiologists, pain medicine specialists, and healthcare providers performing regional anesthesia or interventional pain procedures. ### PM Action Plan (Next Best Moves) - [ ] [PIVOT] [HIGH IMPACT] Grandfather legacy users into the current subscription tier because the lack of access for prior purchasers is the #1 sentiment driver → restore brand trust — *Sentiment analysis identifies forced subscription as the primary cause of the 1.27-star rating.* _(trade-off: deprioritize Pause the annual subscription revenue growth target for Q1 — legacy retention is a prerequisite for long-term brand health.)_ - [ ] [MAINTAIN] [HIGH IMPACT] Audit and stabilize the login flow because technical instability is reported as a circular failure → reduce churn — *Users report the application has become unstable and prone to crashing post-update.* _(trade-off: deprioritize Delay the 2026 interventional pain guideline UI refresh — stability is the current baseline requirement.)_ ### Feature Gaps vs Competitors - Integrated clinical calculators (available in Anesthesia Central but absent here) - Institutional EHR integration (available in Calculate by QxMD but absent here) ### Outlook: Declining The medical reference market is consolidating around high-frequency, multi-tool apps that prioritize stability and integration. ASRA Coags is currently exposed due to its infrequent update cycle and the reputational damage caused by the subscription transition, which will likely lead to further user churn unless the legacy access issue is resolved. - 🔴 The transition to a subscription model has triggered a severe backlash from the professional medical user base, which is driving users to abandon the app. - 🔴 Technical instability and application crashes reported following the transition to the new build are eroding the daily active habit. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 1.23/5 | | Total Reviews | 578 | | Sentiment | Upset (15/100) | | Confidence | High | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **ASRA Coags** (this app) | 1.23/5 | Upset | American Society of Regional Anesthesia and Pain Medicine | | [Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) | 4.8/5 | N/A | Doximity | | [Vargo Anesthesia Mega App](https://marlvel.ai/intel-report/medical/com-insertnamehere-vargomasterapp) | 4.7/5 | N/A | Vargo Anesthesia Inc | | [Pedi STAT](https://marlvel.ai/intel-report/medical/com-qxmd-pedsguide) | 4.5/5 | N/A | James M Kempema MD PA | | [UpToDate](https://marlvel.ai/intel-report/medical/uptodate) | 4.3/5 | N/A | UpToDate, Inc. | | [Anesthesia Central](https://marlvel.ai/intel-report/medical/anesthesia-central-1) | 4.7/5 | N/A | Unbound Medicine, Inc. | ## Company Profile - **Developer:** American Society of Regional Anesthesia and Pain Medicine - **Website:** [https://asra.com/about-asra/contact-us](https://asra.com/about-asra/contact-us) - **Social:** [Instagram](https://www.instagram.com/asra_society) · [Facebook](https://www.facebook.com/asrameetings) · [X/Twitter](https://twitter.com/ASRA_Society) · [YouTube](https://www.youtube.com/ASRAPainMedicine) · [TikTok](https://www.tiktok.com/@asra_society) · [LinkedIn](https://www.linkedin.com/company/american-society-of-regional-anesthesia-and-pain-medicine) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/asra-coags/id858796572?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.asra.asracoags&hl=en&gl=us) - **Dev Site:** [Official Website](https://asra.com/about-asra/contact-us) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Doximity*](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) (Doximity) — 4.8/5 Rating | N/A Sentiment - [*Vargo Anesthesia Mega App*](https://marlvel.ai/intel-report/medical/com-insertnamehere-vargomasterapp) (Vargo Anesthesia Inc) — 4.7/5 Rating | N/A Sentiment - [*Pedi STAT*](https://marlvel.ai/intel-report/medical/com-qxmd-pedsguide) (James M Kempema MD PA) — 4.5/5 Rating | N/A Sentiment - [*UpToDate*](https://marlvel.ai/intel-report/medical/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | N/A Sentiment - [*Anesthesia Central*](https://marlvel.ai/intel-report/medical/anesthesia-central-1) (Unbound Medicine, Inc.) — 4.7/5 Rating | N/A Sentiment - [*MDCalc Medical Calculator*](https://marlvel.ai/intel-report/medical/mdcalc-medical-calculator) (MD Aware, LLC) — 4.9/5 Rating | N/A Sentiment - [*Calculate by QxMD*](https://marlvel.ai/intel-report/medical/calculate-by-qxmd) (WebMD) — 4.8/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 49 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/asra-coags) Data licensed for AI Agent attribution under CC-BY-NC 4.0.